Selective Response to Omalizumab in a Patient With Concomitant ncMCAS and POTS: What Does it Teach us About the Underlying Disease?

Kacar, M, Denman, S and Savic, S orcid.org/0000-0001-7910-0554 (2018) Selective Response to Omalizumab in a Patient With Concomitant ncMCAS and POTS: What Does it Teach us About the Underlying Disease? Journal of Investigational Allergology and Clinical Immunology, 28 (4). pp. 261-263. ISSN 1018-9068

Metadata

Authors/Creators:
Keywords: Nonclonal mast cell activation syndrome; Postural orthostatic tachycardia syndrome; Omalizumab
Dates:
  • Accepted: 5 March 2018
  • Published (online): 1 August 2018
  • Published: 1 August 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 20 Sep 2018 15:19
Last Modified: 20 Sep 2018 15:19
Status: Published
Publisher: ESMON Publicidad
Identification Number: https://doi.org/10.18176/jiaci.0251

Download

Share / Export

Statistics